Tildrakizumab-Asm 100 mg/mL Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 100 mg/mL
Reference Brands: Ilumya (USA), Ilumetri (EUUK)
Category: Derma Drugs
Tildrakizumab-asmn is a humanized IgG1/k monoclonal antibody that selectively targets the p19 subunit of interleukin-23 (IL-23). By blocking IL-23 signaling, it reduces inflammation and helps clear plaques in moderate to severe plaque psoriasis. It is prescribed for adults who need systemic therapy or phototherapy. The dosing schedule includes injections at week 0, week 4, and every 12 weeks thereafter. It is administered as a subcutaneous injection under medical supervision.
Tildrakizumab-Asm — third party manufacturing & bulk supply
Tildrakizumab-Asm 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tildrakizumab-Asm listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tildrakizumab-Asm →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tildrakizumab-asm is used to treat adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It helps reduce inflammation, skin plaques, redness, and thickness by targeting specific immune pathways involved in psoriasis.
Tildrakizumab-asm is made from the active ingredient tildrakizumab-asm, a humanized monoclonal antibody that selectively blocks interleukin-23 (IL-23), along with standard excipients used in biologic injectable formulations.
The trade name for tildrakizumab-asm is Ilumya (in the USA) and Ilumetri (in the EU and other regions).
Tildrakizumab-asm is manufactured and marketed by Sun Pharma in the USA, EU, UK, and other approved global markets.
The generic name is tildrakizumab-asm.
The brand names are Ilumya and Ilumetri, depending on the country.
It is manufactured in approved biologics manufacturing facilities in the USA and Europe, as well as other globally regulated regions authorized for monoclonal antibody production.
Related Products
Sofpironium Bromide
Strength:
5%, 12.45%
Form: Topical Gel
Reference Brands: ECCLOCK, Sofdra
View Details
Sarecycline
Strength:
60 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Seysara (USA)
View Details
Afamelanotide
Strength:
16 mg
Form: Subcutaneous implant
Reference Brands: Scenesse (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
